MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Deep Brain Stimulation in Parkinson’s Disease Patients: A One Year Follow-up in the Understudied Geography of Brazil

    M. Faria, A. Novicki, F. Godinho, Y. Souza, J. Woods, K. Stromberg, R. Paolillo, C. Rocha (Belo Horizonte, Brazil)

    Objective: This study aimed to evaluate the role of deep brain stimulation (DBS) in the improvement of health-related quality of life (HR QoL) outcomes in…
  • 2023 International Congress

    parkinson’s disease and coffee: is high consumption a protective factor or aversion to coffee taste a risk factor?

    G. Procópio, C. Lobo, H. Dourado, MA. Silveira, AE. Lima, I. Oliveira, L. de Almeida, G. Valença (Salvador, Brazil)

    Objective: To evaluate the association between coffee consumption and preference for the taste of coffee with Parkinson's Disease (PD). Background: Previous studies point to a…
  • 2023 International Congress

    Generalized chorea, cerebellar ataxia and spastic tetraparesis with a genetic mutation in FAT2 gene – coincidence or a new SCA45 phenotype?

    M. Sequeira, D. Melancia (Lisboa, Portugal)

    Objective: To present what might be a new phenotype of spinocerebellar ataxia type 45. Background: Spinocerebellar ataxias (SCAs) are a heterogeneous group of autosomal dominant,…
  • 2023 International Congress

    Striatal neurodegeneration in female carriers of the TAF1 Mutation Causing X-linked Dystonia-Parkinsonism

    H. Hanssen, J. Dy, J. Tantianpact, M. Heldmann, H. Manalo, C. Klein, A. Westenberger, J. Oropilla, C. Diesta, N. Brüggemann (Lübeck, Germany)

    Objective: To determine whether structural brain changes are present in female carriers (MC) of the TAF1 pathogenic change causing X-linked dystonia-parkinsonism (XDP). Background: XDP is an X-linked…
  • 2023 International Congress

    Comparing neuromelanin intensity estimation techniques for Parkinson’s disease image analysis

    V. Madge, V. Fonov, A. Bailey, A. Dagher, E. Fon, R. Postuma, DL. Collins (Montréal, Canada)

    Objective: The objective of this study is to compare robust neuromelanin (NM) substantia nigra pars compacta (SN) and locus coeruleus (LC) quantification techniques captured in…
  • 2023 International Congress

    Levodopa-carbidopa intestinal gel for managing severe refractory tremors of idiopathic Parkinson’s disease: Case Series

    M. Abu Al-Melh, N. Abdelall, T. Al-Otaibi (Ahmadi governorate, Kuwait)

    Objective: To report our experience with the use of levodopa-carbidopa intestinal gel (LCIG) infusion therapy for the treatment of four patients with idiopathic Parkinson’s disease…
  • 2023 International Congress

    Oculomotor findings in paraneoplastic neurological syndromes with cerebellar ataxia

    A. Milovanović, I. Basta, N. Kresojević, O. Tamaš, A. Tomić Pešić, I. Stanković Tutuš, M. Svetel, VS. Kostić, NT. Dragašević Mišković (Belgrade, Serbia)

    Objective: This study aimed to evaluate oculomotor disturbances in paraneoplastic cerebellar syndromes. Background: Paraneoplastic cerebellar syndrome is an immune-mediated disorder triggered by neoplastic lesion in…
  • 2023 International Congress

    Progressive myoclonic epilepsy ataxia syndrome associated with NUS1 gene mutation

    R. Vasireddy, M. Bensalem-Owen, Z. Guduru (Lexington, USA)

    Objective: To describe a rare case of NUS1 gene mutation related progressive epilepsy myoclonus ataxia syndrome. Background: Pathogenic variants of NUS1 gene have been associated…
  • 2023 International Congress

    Childhood-onset writer’s cramp evolving to generalised dystonia –a new mutation in KMT2B gene

    M. Sequeira, M. Soares, J. Rosa (Lisboa, Portugal)

    Objective: To present a case of childhood-onset dystonia with a new mutation in KMT2B gene. Background: KMT2B-related dystonia (DYT-KMT2B) is an increasingly recognized cause of…
  • 2023 International Congress

    Exploring the complementary approach of a standardized osteopathic treatment protocol on sleep quality in Parkinsons disease: A randomized controlled study

    S. Yao, J. Difrancisco-Donoghue, A. Leder, J. Mancini, J. Docherty (Old Westbury, USA)

    Objective: To investigate the complementary effects of a standardized Osteopathic Manipulative Treatment (OMT) Protocol on sleep quality using the Pittsburgh Sleep Index (PSQI) Background: Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 446
  • 447
  • 448
  • 449
  • 450
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley